Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited-Reference-Cited by-同舟云学术

Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited

Published:2010-11-26 Issue:2 Volume:54 Page:233-236
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Frier B. M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-010-1983-6.pdf

Reference27 articles.

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

2. Jacobson AM, Ryan CM, Cleary PA, and the DCCT/EDIC Research Group et al (2011) Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia. doi: 10.1007/s00125-010-1883-9

3. Deary IJ, Frier BM (1996) Severe hypoglycaemia and cognitive impairment in diabetes. Link not proven. BMJ 313:767–768

4. The Diabetes Control and Complications Trial Research Group (1996) Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379–388

5. Austin EJ, Deary IJ (1999) Effects of repeated hypoglycemia on cognitive function. A psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 22:1273–1277

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes mellitus und Demenz;Geriatrie up2date;2022-01

2. Diabetes mellitus und Demenz;Diabetologie und Stoffwechsel;2021-12

3. Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia;The Journal of Clinical Endocrinology & Metabolism;2020-11-12

4. Neural dysfunction and retinopathy in persons with type 1 diabetes;Ophthalmic Epidemiology;2018-07-09

5. Esculin ameliorates cognitive impairment in experimental diabetic nephropathy and induces anti-oxidative stress and anti-inflammatory effects via the MAPK pathway;Molecular Medicine Reports;2018-03-13